Eltrombopag for Adults and Children with Immune-Refractory Thrombocytopenic Purpura: A Systematic Review
Eltrombopag is an agonist that binds to the membrane-bound domain of the thrombopoietin receptor used in immune thrombocytopenic purpura (ITP). We conducted a meta-analysis of randomized controlled trials to assess the efficacy and safety of eltrombopag in adults and children with refractory ITP. Ad...
Main Authors: | Danielle Francisco Honorato de Barros Torelli, Crystian Bitencourt Soares Oliveira, Gisele Alborghetti Nai, Evelinda Marramon Trindade, Luiz Euribel Prestes-Carneiro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/12/3872 |
Similar Items
-
Immune thrombocytopenic purpura
by: Abir Zainal, et al.
Published: (2019-01-01) -
Immune thrombocytopenic purpura in a patient with disseminated tuberculosis: An unusual presentation
by: Prashant Nasa, et al.
Published: (2019-01-01) -
Pathological Mechanisms and Novel Testing Methods in Thrombotic Thrombocytopenic Purpura
by: Hallie H. Dolin, et al.
Published: (2024-03-01) -
Low-Dose Eltrombopag in a Patient with Chronic Idiopathic Thrombocytopenic Purpura Post Sleeve Gastrectomy
by: Mohanad A. Ahmed, et al.
Published: (2020-06-01) -
Acute Myocardial Infarction Due to Eltrombopag Therapy in a Patient with Immune Thrombocytopenic Purpura
by: Sena Sert, et al.
Published: (2017-03-01)